Sign inGet started

ASND

Ascendis Pharma A/SCIK 1612042 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
$985.3K
4 trades · 1 insiders
Open-mkt sales · 90d
$1.75M
4 trades · 2 insiders
Net · 90d
$-760.5K
Insiders on file
5

AI insights for ASND PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for ASND
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

$1.62M2026-08-14 buys $985.3K 2026-08-14 sales —08-142026-09-02 buys — 2026-09-02 sales $124.7K09-022026-09-08 buys — 2026-09-08 sales $1.62M09-08
■ Open-market buys (P)   ■ Open-market sales (S) · daily dollar value by transaction date

Insiders

InsiderRoleTradesBoughtSoldLast trade
Bodenhoff MadsSVP & PAO6$0$1.62M2026-09-08
HOLTUG LARSDirector2$0$124.7K2026-09-02
BIENAIME JEAN JACQUESDirector13$1.19M$02026-08-14
SMITH SCOTT THOMASEVP & Chief Financial Officer2$77.7K$02026-06-02
JENSEN FLEMMING STEENSee Remarks1$0$4.64M2026-05-11

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
Bodenhoff MadsSVP & PAO M Exercise deriv2026-09-082026-09-093,000— $0687SEC↗
Bodenhoff MadsSVP & PAO S Sale2026-09-082026-09-093,000$270.19 $810.6K0SEC↗
Bodenhoff MadsSVP & PAO M Exercise2026-09-082026-09-093,000$110.00 $330.0K3,000SEC↗
Bodenhoff MadsSVP & PAO M Exercise deriv2026-09-082026-09-093,000— $0687SEC↗
Bodenhoff MadsSVP & PAO S Sale2026-09-082026-09-093,000$270.19 $810.6K0SEC↗
Bodenhoff MadsSVP & PAO M Exercise2026-09-082026-09-093,000$110.00 $330.0K3,000SEC↗
HOLTUG LARSDirector S Sale2026-09-022026-09-03236$264.13 $62.3K4,000SEC↗
HOLTUG LARSDirector S Sale2026-09-022026-09-03236$264.13 $62.3K4,000SEC↗
BIENAIME JEAN JACQUESDirector P Buy2026-08-142026-08-18900$246.91 $222.2K2,900SEC↗
BIENAIME JEAN JACQUESDirector P Buy2026-08-142026-08-181,100$245.85 $270.4K2,000SEC↗
BIENAIME JEAN JACQUESDirector P Buy2026-08-142026-08-18900$246.91 $222.2K2,900SEC↗
BIENAIME JEAN JACQUESDirector P Buy2026-08-142026-08-181,100$245.85 $270.4K2,000SEC↗
SMITH SCOTT THOMASEVP & Chief Financial Office P Buy2026-06-022026-06-02100$219.00 $21.9K4,367SEC↗
SMITH SCOTT THOMASEVP & Chief Financial Office P Buy2026-05-292026-06-01250$223.32 $55.8K4,267SEC↗
BIENAIME JEAN JACQUESDirector P Buy2026-05-292026-06-01200$222.30 $44.5K800SEC↗
BIENAIME JEAN JACQUESDirector P Buy2026-05-292026-06-01100$223.50 $22.4K900SEC↗
BIENAIME JEAN JACQUESDirector P Buy2026-05-292026-06-01200$223.76 $44.8K600SEC↗
BIENAIME JEAN JACQUESDirector P Buy2026-05-262026-05-27200$236.24 $47.2K200SEC↗
BIENAIME JEAN JACQUESDirector P Buy2026-05-262026-05-27200$239.37 $47.9K400SEC↗
JENSEN FLEMMING STEENSee Remarks S Sale2026-05-112026-05-1219,460$238.49 $4.64M0SEC↗
BIENAIME JEAN JACQUESDirector D To issuer deriv2026-04-142026-09-289,160— $00SEC↗
BIENAIME JEAN JACQUESDirector A Award deriv2026-04-142026-09-289,160— $09,160SEC↗
BIENAIME JEAN JACQUESDirector A Award deriv2026-04-142026-09-289,160— —9,160SEC↗
BIENAIME JEAN JACQUESDirector D To issuer deriv2026-04-142026-09-289,160— —0SEC↗